Interleukin-18 gene polymorphism in patients with and without atherosclerotic coronary artery disease

Iranian Cardiovascular Research Journal

Volumn 3, Issue 3, 2009, Pages 158-163

  Shayan, S ^a   Abdi, A R ^a   Zibaeenezhad, M J ^a   Haghshenas, M R ^b   Erfani, N ^b   Ghaderi, A ^b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Atherosclerotic coronary artery disease; Haplotype; IL 18

Indexed keywords

GENOMIC DNA; INTERLEUKIN 18;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IRAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 73449091126     PISSN: 1735885X     EISSN: 17358868     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002;105:1135-43. [11877368]
2. McInnes IB, Gracie JA, Leung BP, et al. Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 2000;21:312-5. [10871869]
3. Mallat Z, Corbaz A, Scoazec A, et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation 2001;104:1598-603. [11581135].
4. Nakanishi K, Yoshimoto T, Tsutsui H, et al. Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev 2001;12:53-72. [11312119].
5. Cheng X, Ding Y, Xia C, et al. Atorvastatin modulates Th1/ Th2 response in patients with chronic heart failure. J Card Fail 2009;15:158- 62. [19254676]
6. Vidal-Vanaclocha F, Fantuzzi G, Mendoza L, et al. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. Proc Natl Acad Sci U S A 2000;97:7349 [10639148].
7. Gerdes N, Sukhova GK, Libby P, et al. Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis. J Exp Med 2002;195:245-57. [11805151]
8. Elhage R, Jawien J, Rudling M, et al. Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice. Cardiovasc Res 2003;59:234-40. [12829194]
9. Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma. Circ Res 2002;90:E34-8. [11834721]
10. Blankenberg S, Luc G, Ducimetiere P, et al. Interleukin-18 and the risk of coronary heart disease in European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation 2003;108:2453-9. [14581397]
11. Mallat Z, Corbaz A, Scoazec A, et al. Interleukin-18/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability. Circ Res 2001;89:E41-5. [11577031]
12. Giedraitis V, He B, Huang WX, et al. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001;112:146-52. [11108943]
13. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215. [3344216]
14. Tiret L, Godefroy T, Lubos E, et al. Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease. Circulation 2005;112:643-50. [16043644]
15. Pei F, Han Y, Zhang X, et al. Association of interleukin-18 gene promoter polymorphisms with risk of acute myocardial infarction in northern Chinese Han population. Clin Chem Lab Med 2009;47:523-9. [19309308]
16. Hernesniemi JA, Karhunen PJ, Rontu R, et al. Interleukin-18 promoter polymorphism associates with the occurrence of sudden cardiac death among Caucasian males: the Helsinki Sudden Death Study. Atherosclerosis 2008;196:643-9 [17765248].
17. Liu W, Tang Q, Jiang H, et al. Promoter polymorphism of interleukin-18 in angiographically proven coronary artery disease. Angiology 2009;60:180-5. [18599493]
18. Evans J, Collins M, Jennings C, et al. The association of interleukin-18 genotype and serum levels with metabolic risk factors for cardiovascular disease. Eur J Endocrinol 2007;157:633-40. [17984243]
19. Jain S, Shah M, Li Y, et al. Upregulation of human angiotensinogen (AGT) gene transcription by interferon-gamma: involvement of the STAT1-binding motif in the AGT promoter. Biochim Biophys Acta 2006;1759:340-7. [16949687]
20. Thompson SR, Sanders J, Stephens JW, et al. A common interleukin 18 haplotype is associated with higher body mass index in subjects with diabetes and coronary heart disease. Metabolism 2007;56:662-9. [17445542]
21. Skurk T, Kolb H, Muller-Scholze S, et al. The proatherogenic cytokine interleukin-18 is secreted by human adipocytes. Eur J Endocrinol 2005;152:863-8. [15941925]
22. Esposito K, Pontillo A, Ciotola M, et al. Weight loss reduces interleukin-18 levels in obese women. J Clin Endocrinol Metab 2002;87:3864-6. [12161523]
23. Hung J, McQuillan BM, Chapman CM, et al. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arterioscler Thromb Vasc Biol 2005;25:1268-73. [15790931]